Sign In
Buy PDSB
$1.08
-0.0800 (-6.90%)
At Close: Jun 03, 2026
PDS Biotech to Host Oncology R&D Day on June 16, 2021
08:27am, Tuesday, 01'st Jun 2021
FLORHAM PARK, N.J., June 01, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company's prop
Implied Volatility Surging for PDS Biotechnology (PDSB) Stock Options
04:32pm, Monday, 24'th May 2021
Investors need to pay close attention to PDS Biotechnology (PDSB) stock based on the movements in the options market lately.
Implied Volatility Surging for PDS Biotechnology (PDSB) Stock Options
09:01am, Monday, 24'th May 2021
Investors need to pay close attention to PDS Biotechnology (PDSB) stock based on the movements in the options market lately.
PDS Biotech to Host Company Conference Call Following Oral Presentation of PDS0101 Data at 2021 ASCO Annual Meeting
08:07am, Monday, 24'th May 2021
FLORHAM PARK, N.J., May 24, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company's propr
PDSB Stock Price: Over 6% Increase Pre-Market Explanation
06:52am, Monday, 24'th May 2021
The stock price of PDS Biotechnology Corp (NASDAQ: PDSB) increased by over 6% pre-market. This is why it happened.
PDSB Stock Price: 14.58% Increase Explanation
08:59pm, Sunday, 23'rd May 2021
The stock price of PDS Biotechnology Corp (NASDAQ: PDSB) increased by 14.58% on Friday, May 21. This is why it happened.
Oppenheimer Has 5 Sizzling Biotech Stocks to Buy Now Trading Under $10
06:15am, Saturday, 22'nd May 2021
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
NetScientific hails the potential of investee company's cancer immunotherapy
02:52am, Friday, 21'st May 2021
NetScientific PLC (LON:NSCI) said an investee company will share additional data that will underline the potential efficacy of a breakthrough cancer immunotherapy. PDS Biotechnology Corporation (NASDA
PDS Biotechnology (PDSB) Stock: 26.66% Increase Explanation
09:50pm, Thursday, 20'th May 2021
The stock price of PDS Biotechnology Corp (NASDAQ: PDSB) increased by 26.66% today. This is why it happened.
Small-Cap & Penny Stocks To Watch In May Hitting It Big In 2021
11:16am, Thursday, 20'th May 2021
Penny stocks that left the nest in 2021 To Watch Right Now The post Small-Cap & Penny Stocks To Watch In May Hitting It Big In 2021 appeared first on Penny Stocks to Buy, Picks, News and Information |
PDS Biotech Announces Release of Abstract for PDS0101 in NCI-Led Phase 2 Clinical Study for Oral Presentation at 2021 ASCO Meeting
08:00am, Thursday, 20'th May 2021
Objective responses (tumor reduction) observed in 83% (5 of 6) of HPV16-positive relapsed or refractory checkpoint inhibitor naïve patients and 63% (5 of 8) of HPV16-positive relapsed or refractory a
NetScientific portfolio firm PDS Biotech sells off New Jersey tax benefits
03:49am, Tuesday, 18'th May 2021
NetScientific PLC (LON:NSCI) said its portfolio firm, PDS Biotechnology Corp (NASDAQ:PDSB), it which it owns a 5.75% stake, has received US$4.5mln from the net sale of tax benefits to an unrelated, pr
PDS Biotechnology Corp (PDSB) CEO Frank Bedu-Addo on Q1 2021 Results - Earnings Call Transcript
01:44pm, Thursday, 13'th May 2021
PDS Biotechnology Corp (PDSB) CEO Frank Bedu-Addo on Q1 2021 Results - Earnings Call Transcript
PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results
07:00am, Thursday, 13'th May 2021
FLORHAM PARK, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vacci
PDS Biotech Advances the Fight Against Cancer with its Versamune® Platform
10:01am, Monday, 03'rd May 2021
PDS Biotechnology Corporation (NASDAQ: PDSB) will be reporting preliminary Phase 2 clinical data of its lead compound PDS0101 for the treatment of advanced HPV-associated cancers in patients whose can
